Disulfide-stabilized diabody antiCD19/antiCD3 exceeds its parental antibody in tumor-targeting activity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Disulfide-stabilized diabody antiCD19/antiCD3 exceeds its parental antibody in tumor-targeting activity

Published:2012-10-09 Issue:6 Volume:35 Page:423-434
ISSN:2211-3428
Container-title:Cellular Oncology
language:en
Short-container-title:Cell Oncol.

Author:

Wei Li,DongMei Fan,Ming Yang,RuiZan Shi,Yan Yan,Linlin Jiang,Cihui Yan,Shuangjing Li,Min Wang,Jianxiang Wang,DongSheng Xiong

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13402-012-0101-9.pdf

Reference33 articles.

1. C. Andreadis, S.J. Schuster, E.A. Chong, J. Svoboda, S.M. Luger, D.L. Porter et al., Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma. Bone Marrow Transplant. 36, 955–961 (2005)

2. B. Reismüller, A. Attarbaschi, C. Peters, M.N. Dworzak, U. Pötschger, C. Urban et al., Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria—a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group. Br. J. Haematol. 144, 559–570 (2009)

3. P. Tsirigotis, T. Economopoulos, Monoclonal antibodies in the treatment of lymphoid malignancies. J. Steroid Biochem. Mol. Biol. 108, 267–271 (2008)

4. E. Oflazoglu, L.P. Audoly, Evolution of anti-CD20 monoclonal antibody therapeutics in oncology. MABS. 2, 14–19 (2010)

5. J.O. Richards, S. Karki, G.A. Lazar, H. Chen, W. Dang, J.R. Desjarlais, Optimization of antibody binding to FcgammaRIIa enhances macrophage phagocytosis of tumor cells. Mol. Cancer Ther. 7, 2517–2527 (2008)

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential scanning fluorimetry as a measure of functionality of refolded anti-malarial antibody fragments;2022-09-02

2. A Novel CD3/BCMA Bispecific T-cell Redirecting Antibody for the Treatment of Multiple Myeloma;Journal of Immunotherapy;2021-10-27

3. Immunotargeting and therapy of cancer by advanced multivalence antibody scaffolds;Journal of Drug Targeting;2020-06-09

4. Building blocks for bispecific and trispecific antibodies;Methods;2019-02

5. Mesenchymal stromal cells as vehicles of tetravalent bispecific Tandab (CD3/CD19) for the treatment of B cell lymphoma combined with IDO pathway inhibitor d-1-methyl-tryptophan;Journal of Hematology & Oncology;2017-02-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3